Netherlands· NL-99daaec165e6
Climodien 1 mg/2 mg, omhulde tabletten
A dienogest und estrogen product containing dienogest + estradiolvaleraat, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 5 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Dienogest und estrogen is registered in 5 of 19 countries.
Countries holding a registration under ATC G03FA15 (dienogest und estrogen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Dienogest und estrogen · ATC G03FA15
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DIENOGEST + ESTRADIOLVALERAAT
- Manufacturer
- Bayer B.V.
- Country
- Netherlands (NL)
- ATC code
- G03FA15
- ATC class
- Dienogest und Estrogen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id30401
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dienogest und estrogen in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAUDERAAristo Pharma GmbH, Berlin
- SwitzerlandEstelle, FilmtablettenSpirig HealthCare AG
- PolandElliadeZakłady Farmaceutyczne POLPHARMA S.A.
- GermanyArioraGedeon Richter Plc.
- SpainAIQLARA COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Cinfa S.A.
- United KingdomEstradiol valerate 2mg / Dienogest 2mg tabletsBayer Plc
- FranceQLAIRA, comprimé pelliculéBAYER HEALTHCARE
- IrelandQlaira film-coated tabletsBayer Limited
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Velbienne
- Belgium · Laclimella, Velbienne
- Czechia · Audera, Velbienne
- Germany · Ariora, Dielera
- Estonia · Velbienne
- Spain · Velbienne
- Italy · Damsel, Paudien
- Lithuania · Velbienne
- Luxembourg · Laclimella, Velbienne
- Latvia · Velbienne
- Poland · Juvinelle, Velbienne Mini
- Portugal · Clifemme
- Sweden · Audera, Idilla
- Slovakia · Velbienne
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/24cb5f57-9fa1-4f49-8c49-7f808968ab2d GET /v1/drugs/24cb5f57-9fa1-4f49-8c49-7f808968ab2d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Omhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h30401_smpc.pdf",
"strength": null,
"atc_label": "Dienogest And Estrogen",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg30401",
"excipients": [
"CALCIUMCARBONAAT (E 170)",
"CARNAUBAWAS (E 903)",
"GLUCOSE, VLOEIBAAR",
"IJZEROXIDE ROOD (E 172)",
"LACTOSE 1-WATER",
"MACROGOL 35000",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"MAÏSZETMEEL, GEPREGELATINEERD",
"POVIDON K 25 (E 1201)",
"SACCHAROSE",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"DIENOGEST",
"ESTRADIOLVALERAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h30401.pdf",
"authorised_at": "2005/02/14",
"procedure_number": "NL/H/0595/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "30401",
"additional_monitoring": "N"
}See everything about dienogest und estrogen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.